Carsten Bokemeyer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Kollmannsberger Christian; Beyer Joerg; Bokemeyer Carsten
High-dose chemotherapy in nonseminomatous germ cell cancer.
Van Cutsem Eric; Labianca Roberto; Bodoky György; Barone Carlo; Aranda Enrique; Nordlinger Bernard; Topham Claire; Tabernero Josep; André Thierry; Sobrero Alberto F; Mini Enrico; Greil Richard; Di Costanzo Francesco; Collette Laurence; Cisar Laura; Zhang Xiaoxi; Khayat David; Bokemeyer Carsten; Roth Arnaud D; Cunningham David
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.
Stang Axel; Fischbach Roman; Teichmann Wolfgang; Bokemeyer Carsten; Braumann Dietrich
A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Carsten Bokemeyer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kollmannsberger Christian; Beyer Joerg; Bokemeyer Carsten
High-dose chemotherapy in nonseminomatous germ cell cancer.
BJU international 2009;104(9 Pt B):1398-403.
2009: Van Cutsem Eric; Labianca Roberto; Bodoky György; Barone Carlo; Aranda Enrique; Nordlinger Bernard; Topham Claire; Tabernero Josep; André Thierry; Sobrero Alberto F; Mini Enrico; Greil Richard; Di Costanzo Francesco; Collette Laurence; Cisar Laura; Zhang Xiaoxi; Khayat David; Bokemeyer Carsten; Roth Arnaud D; Cunningham David
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(19):3117-25.
2009: Stang Axel; Fischbach Roman; Teichmann Wolfgang; Bokemeyer Carsten; Braumann Dietrich
A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.
European journal of cancer (Oxford, England : 1990) 2009;45(10):1748-56.
2009: Haubold Katja; Rink Michael; Spath Brigitte; Friedrich Martin; Chun Felix Kyoung-Hwan; Marx Guy; Amirkhosravi Ali; Francis John L; Bokemeyer Carsten; Eifrig Barbara; Langer Florian
Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Thrombosis and haemostasis 2009;101(6):1147-55.
2009: Zustin J; Boddin K; Tsourlakis M C; Burandt E; Mirlacher M; Jaenicke F; Izbicki J; Ruether W; Rueger J M; Bokemeyer C; Simon R; Sauter G
HER-2/neu analysis in breast cancer bone metastases.
Journal of clinical pathology 2009;62(6):542-6.
2009: Goekkurt Eray; Al-Batran Salah-Eddin; Hartmann Jörg T; Mogck Ulrike; Schuch Gunter; Kramer Michael; Jaeger Elke; Bokemeyer Carsten; Ehninger Gerhard; Stoehlmacher Jan
Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2863-73.
2009: Ludwig Heinz; Aapro Matti; Bokemeyer Carsten; Macdonald Karen; Soubeyran Pierre; Turner Matthew; Albrecht Tara; Abraham Ivo
Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.
European journal of cancer (Oxford, England : 1990) 2009;45(9):1603-15.
2009: Marx Andreas H; Tharun Lars; Muth Johanna; Dancau Ana-Maria; Simon Ronald; Yekebas Emre; Kaifi Jussuf T; Mirlacher Martina; Brümmendorf Tim H; Bokemeyer Carsten; Izbicki Jakob R; Sauter Guido
HER-2 amplification is highly homogenous in gastric cancer.
Human pathology 2009;40(6):769-77.
2009: Honecker Friedemann; Wermann Hendrik; Mayer Frank; Gillis Ad J M; Stoop Hans; van Gurp Ruud J L M; Oechsle Karin; Steyerberg Ewout; Hartmann Jörg Th; Dinjens Winand N M; Oosterhuis J Wolter; Bokemeyer Carsten; Looijenga Leendert H J
Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2129-36.
2009: Schilling G; Bruweleit M; Harbeck N; Thomssen C; Becker K; Hoffmann R; Villena C; Schütte M; Hossfeld D K; Bokemeyer C; de Wit M
Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy).
Investigational new drugs 2009;27(2):166-72.
2009: Schittenhelm Marcus M; Kollmannsberger Christian; Oechsle Karin; Harlow Amy; Morich Jason; Honecker Friedemann; Kurek Raffael; Störkel Stephan; Kanz Lothar; Corless Christopher L; Wong Kwok-Kin; Bokemeyer Carsten; Heinrich Michael C
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer.
Molecular cancer therapeutics 2009;8(3):481-9.
2009: Atanackovic Djordje; Luetkens Tim; Hildebrandt York; Arfsten Julia; Bartels Katrin; Horn Christiane; Stahl Tanja; Cao Yanran; Zander Axel R; Bokemeyer Carsten; Kröger Nicolaus
Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1343-52.
2009: Schafhausen Philippe; Dierlamm Judith; Bokemeyer Carsten; Bruemmendorf Tim H; Bacher Ulrike; Zander Axel R; Schnittger Susanne; Hochhaus Andreas
Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.
Cancer genetics and cytogenetics 2009;189(1):63-7.
2009: Bokemeyer Carsten; Bondarenko Igor; Makhson Anatoly; Hartmann Joerg T; Aparicio Jorge; de Braud Filippo; Donea Serban; Ludwig Heinz; Schuch Gunter; Stroh Christopher; Loos Anja H; Zubel Angela; Koralewski Piotr
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(5):663-71.
2009: Thöm Ina; Schult-Kronefeld Olaf; Burkholder Iris; Schuch Gunter; Andritzky Birte; Kastendieck Hartwig; Edler Lutz; Wagener Christoph; Bokemeyer Carsten; Schumacher Udo; Laack Eckart
Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastases.
Anticancer research 2009;29(1):249-54.
2009: Honecker Friedemann; Bokemeyer Carsten
[Registries and clinical trials in geriatric oncology in Germany]
Onkologie 2009;32 Suppl 3():14-8.
2009: Bokemeyer Carsten
[In Process Citation]
Onkologie 2009;32 Suppl 3():2.
2009: Vansteenkiste Johan; Hedenus Michael; Gascon Pere; Bokemeyer Carsten; Ludwig Heinz; Vermorken Jan; Hamilton Lisa; Bridges Ken; Pujol Beatriz
Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial.
BMC cancer 2009;9():311.
2008: Langer F; Holstein K; Eifrig B; Bokemeyer C
[Haemostatic aspects in clinical oncology]
Hämostaseologie 2008;28(5):472-80.
2008: Holweger Karin; Lipp Hans-Peter; Dietz Klaus; Hartmann Joerg Thomas; Bokemeyer Carsten
Novel algorithm for more accurate calculation of renal function in adults with cancer.
The Annals of pharmacotherapy 2008;42(12):1749-57.
2008: Gontarewicz Artur; Balabanov Stefan; Keller Gunhild; Panse Jens; Schafhausen Philippe; Bokemeyer Carsten; Fiedler Walter; Moll Jürgen; Brümmendorf Tim H
PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.
Leukemia research 2008;32(12):1857-65.
2008: Vermorken Jan B; Mesia Ricard; Rivera Fernando; Remenar Eva; Kawecki Andrzej; Rottey Sylvie; Erfan Jozsef; Zabolotnyy Dmytro; Kienzer Heinz-Roland; Cupissol Didier; Peyrade Frederic; Benasso Marco; Vynnychenko Ihor; De Raucourt Dominique; Bokemeyer Carsten; Schueler Armin; Amellal Nadia; Hitt Ricardo
Platinum-based chemotherapy plus cetuximab in head and neck cancer.
The New England journal of medicine 2008;359(11):1116-27.
2008: Panse J; Friedrichs K; Marx A; Hildebrandt Y; Luetkens T; Barrels K; Horn C; Stahl T; Cao Y; Milde-Langosch K; Niendorf A; Kröger N; Wenzel S; Leuwer R; Bokemeyer C; Hegewisch-Becker S; Atanackovic D
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.
British journal of cancer 2008;99(6):930-8.
2008: Kollmannsberger C; Honecker F; Bokemeyer C
Pharmacotherapy of relapsed metastatic testicular cancer.
Expert opinion on pharmacotherapy 2008;9(13):2259-72.
2008: Kollmannsberger Christian; Bokemeyer Carsten
Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
Current opinion in supportive and palliative care 2008;2(3):167-72.
2008: Glaesener Stephanie; Honecker Friedemann; Veltman Imke M; Gillis Ad J M; Rohlfing Tina; Streichert Thomas; Otto Benjamin; Brummendorf Tim H; Looijenga Leendert H J; Bokemeyer Carsten; Balabanov Stefan
Comparative proteome, transcriptome, and genome analysis of a gonadal and an extragonadal germ cell tumor cell line.
Journal of proteome research 2008;7(9):3890-9.
2008: Stoop H; Honecker F; van de Geijn G J M; Gillis A J M; Cools M C; de Boer M; Bokemeyer C; Wolffenbuttel K P; Drop S L S; de Krijger R R; Dennis N; Summersgill B; McIntyre A; Shipley J; Oosterhuis J W; Looijenga L H J
Stem cell factor as a novel diagnostic marker for early malignant germ cells.
The Journal of pathology 2008;216(1):43-54.
2008: Ayuk Francis A; Atassi Nabil; Schuch Gunther; Mina Sormeh; Fang Lubin; Bokemeyer Carsten; Fehse Boris; Zander Axel R; Kröger Nicolaus
Complement-dependent and complement-independent cytotoxicity of polyclonal antithymocyte globulins in chronic lymphocytic leukemia.
Leukemia research 2008;32(8):1200-6.
2008: Otten Jasmin; Schultze Alexander; Schafhausen Philippe; Otterstetter Svenja; Dierlamm Judith; Bokemeyer Carsten; Brummendorf Tim H; Fiedler Walter; Loges Sonja
Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative.
British journal of haematology 2008;142(1):115-8.
2008: Schilling G; Hansen T; Shimoni A; Zabelina T; Pérez-Simón J-A; Gutierrez N C; Bethge W; Liebisch P; Schwerdtfeger R; Bornhäuser M; Otterstetter S; Penas E M M; Dierlamm J; Ayuk F; Atanackovic D; Bacher U; Bokemeyer C; Zander A; San Miguel J; Nagler A; Kröger N
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(6):1250-5.
2008: Langer Florian; Spath Brigitte; Haubold Katja; Holstein Katharina; Marx Guy; Wierecky Jan; Brümmendorf Tim H; Dierlamm Judith; Bokemeyer Carsten; Eifrig Barbara
Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
Annals of hematology 2008;87(6):451-7.
2008: Peschel Christian; Hartmann Joerg T; Schmittel Alexander; Bokemeyer Carsten; Schneller Folker; Keilholz Ulrich; Buchheidt Dieter; Millan Susana; Izquierdo Miguel Angel; Hofheinz Ralf-Dieter
Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;60(3):374-80.
2008: Hartmann Jorg Thomas; Pintoffl Jan Peter; Kröning Hendrik; Bokemeyer Carsten; Holtmann Martin; Höhler Thomas
Gefitinib in combination with oxaliplatin and 5-fluorouracil in irinotecan-refractory patients with colorectal cancer: a phase I study of the Arbeits gemeinschaft Internistische Onkologie (AIO).
Onkologie 2008;31(5):237-41.
2008: Aapro Matti S; Birgegård Gunnar; Bokemeyer Carsten; Cornes Paul; Foubert Jan; Gascon Pere; Glaspy John; Hellström-Lindberg Eva; Link Hartmut; Ludwig Heinz; Osterborg Anders; Repetto Lazzaro; Soubeyran Pierre
Erythropoietins should be used according to guidelines.
The lancet oncology 2008;9(5):412-3.
2008: Schwab Matthias; Zanger Ulrich M; Marx Claudia; Schaeffeler Elke; Klein Kathrin; Dippon Jürgen; Kerb Reinhold; Blievernicht Julia; Fischer Joachim; Hofmann Ute; Bokemeyer Carsten; Eichelbaum Michel;
Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(13):2131-8.
2008: Laack Eckart; Bokemeyer Carsten; Hossfeld Dieter Kurt
Adjuvant chemotherapy after complete resection of non-small cell lung cancer.
Deutsches Ärzteblatt international 2008;105(14):249-54.
2008: Görn Michael; Habermann Christian R; Anige Manuela; Thöm Ina; Schuch Gunter; Andritzky Birte; Brandl Stefan; Burkholder Iris; Edler Lutz; Hossfeld Dieter Kurt; Bokemeyer Carsten; Laack Eckart
A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC).
Onkologie 2008;31(4):185-9.
2008: Bokemeyer Carsten
Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(11):1783-5.
2008: Gontarewicz Artur; Balabanov Stefan; Keller Gunhild; Colombo Riccardo; Graziano Alessio; Pesenti Enrico; Benten Daniel; Bokemeyer Carsten; Fiedler Walter; Moll Jürgen; Brümmendorf Tim H
Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.
Blood 2008;111(8):4355-64.
2008: Al-Batran Salah-Eddin; Hartmann Joerg Thomas; Probst Stephan; Schmalenberg Harald; Hollerbach Stephan; Hofheinz Ralf; Rethwisch Volker; Seipelt Gernot; Homann Nils; Wilhelm Gerhard; Schuch Gunter; Stoehlmacher Jan; Derigs Hans Günter; Hegewisch-Becker Susanna; Grossmann Johannes; Pauligk Claudia; Atmaca Akin; Bokemeyer Carsten; Knuth Alexander; Jäger Elke;
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1435-42.
2008: Atanackovic Djordje; Cao Yanran; Luetkens Tim; Panse Jens; Faltz Christiane; Arfsten Julia; Bartels Katrin; Wolschke Christine; Eiermann Thomas; Zander Axel R; Fehse Boris; Bokemeyer Carsten; Kroger Nicolaus
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Haematologica 2008;93(3):423-30.
2008: Bokemeyer C; Oechsle K; Honecker F; Mayer F; Hartmann J T; Waller C F; Böhlke I; Kollmannsberger C;
Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):448-53.
2008: Pfreundschuh Michael; Schubert Joerg; Ziepert Marita; Schmits Rudolf; Mohren Martin; Lengfelder Eva; Reiser Marcel; Nickenig Christina; Clemens Michael; Peter Norma; Bokemeyer Carsten; Eimermacher Hartmut; Ho Anthony; Hoffmann Martin; Mertelsmann Roland; Trümper Lorenz; Balleisen Leopold; Liersch Ruediger; Metzner Bernd; Hartmann Frank; Glass Bertram; Poeschel Viola; Schmitz Norbert; Ruebe Christian; Feller Alfred C; Loeffler Markus;
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
The lancet oncology 2008;9(2):105-16.
2008: Atanackovic Djordje; Altorki Nasser K; Cao Yanran; Ritter Erika; Ferrara Cathy A; Ritter Gerd; Hoffman Eric W; Bokemeyer Carsten; Old Lloyd J; Gnjatic Sacha
Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(5):1650-5.
2008: Aapro Matti; Abraham Ivo; Bokemeyer Carsten; Ludwig Heinz; Macdonald Karen; Soubeyran Pierre; Turner Matthew
The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelines.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(2):193-200.
2008: Bartsch Georg; Eggert Katharina; Soker Shay; Bokemeyer Carsten; Hautmann Richard; Schuch Gunter
Combined antiangiogenic therapy is superior to single inhibitors in a model of renal cell carcinoma.
The Journal of urology 2008;179(1):326-32.
2008: Oliveira-Ferrer Leticia; Hauschild Jessica; Fiedler Walter; Bokemeyer Carsten; Nippgen Johannes; Celik Ilhan; Schuch Gunter
Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway.
Journal of experimental & clinical cancer research : CR 2008;27():86.
2008: Atanackovic Djordje; Cao Yanran; Kim Ji-Won; Brandl Stephan; Thom Ina; Faltz Christiane; Hildebrandt York; Bartels Katrin; de Weerth Andreas; Hegewisch-Becker Susanna; Hossfeld Dieter Kurt; Bokemeyer Carsten
The local cytokine and chemokine milieu within malignant effusions.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2008;29(2):93-104.
2007: Hartmann Jörg T; Gauler Thomas; Metzner Bernd; Gerl Arthur; Casper Jochen; Rick Oliver; Horger Marius; Schleicher Jan; Derigs Günter; Mayer-Steinacker Regine; Beyer Jörg; Kuczyk Markus A; Bokemeyer Carsten;
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5742-7.
2007: Reichmann U; Bokemeyer C; Wallwiener D; Bamberg M; Huober J
Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):1981-4.
2007: Welz Stefan; Hehr Thomas; Kollmannsberger Christian; Bokemeyer Carsten; Belka Claus; Budach Wilfried
Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer.
International journal of radiation oncology, biology, physics 2007;69(5):1429-35.
2007: Langer Florian; Steinmetz Oliver; Marx Guy; Amirkhosravi Ali; Eifrig Barbara; Bokemeyer Carsten; Brümmendorf Tim
Aprotinin-associated hemolytic thrombotic microangiopathy in a patient with acute myelogenous leukemia (AML) and systemic coagulopathy.
American journal of hematology 2007;82(12):1122-4.
2007: Mueller Sandra; Hartmann Ulrike; Mayer Frank; Balabanov Stefan; Hartmann Joerg T; Brummendorf Tim H; Bokemeyer Carsten
Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.
Investigational new drugs 2007;25(6):519-24.
2007: Aapro Matti; Abraham Ivo; MacDonald Karen; Soubeyran Pierre; Foubert Jan; Bokemeyer Carsten; Muenzberg Michael; Van Erps Joanna; Turner Matthew
Intraclass correlation metrics for the accuracy of algorithmic definitions in a computerized decision support system for supportive cancer care.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(11):1325-9.
2007: Lorch Anja; Beyer Jörg; Bokemeyer Carsten
Germ-cell tumors.
The New England journal of medicine 2007;357(17):1772-3; author reply 1773-4.
2007: Bartsch G; Eggert K; Soker S; Fiedler W; Laack E; Volkmer B G; Gschwend J; Bokemeyer C; Hautmann R; Schuch G
[Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma]
Der Urologe. Ausg. A 2007;46(9):1289-90.
2007: Laack Eckart; Thöm Ina; Krüll Andreas; Engel-Riedel Walburga; Müller Thomas; Meissner Christoph; Dürk Heinz; Fischer Jürgen; Gütz Sylvia; Kortsik Cornelius; Elbers Matthias; Schuch Gunter; Andritzky Birte; Görn Michael; Burkholder Iris; Edler Lutz; Hossfeld Dieter Kurt; Bokemeyer Carsten
A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC).
Lung cancer (Amsterdam, Netherlands) 2007;57(2):181-6.
2007: Burkart Christof; Bokemeyer Carsten; Klump Bodo; Pereira Philippe; Teichmann Reinhard; Hartmann Jörg Thomas
A phase II trial of weekly irinotecan in cisplatin-refractory esophageal cancer.
Anticancer research 2007;27(4C):2845-8.
2007: Heuser Michael; Ganser Arnold; Bokemeyer Carsten;
Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.
Seminars in hematology 2007;44(3):148-56.
2007: Lorch Anja; Kollmannsberger Christian; Hartmann Joerg Thomas; Metzner Bernd; Schmidt-Wolf Ingo G H; Berdel Wolfgang E; Weissinger Florian; Schleicher Jan; Egerer Gerlinde; Haas Antje; Schirren Rebekka; Beyer Jörg; Bokemeyer Carsten; Rick Oliver;
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2778-84.
2007: Loges Sonja; Butzal Martin; Otten Jasmin; Schweizer Michaela; Fischer Uta; Bokemeyer Carsten; Hossfeld Dieter K; Schuch Gunter; Fiedler Walter
Cilengitide inhibits proliferation and differentiation of human endothelial progenitor cells in vitro.
Biochemical and biophysical research communications 2007;357(4):1016-20.
2007: Thöm Ina; Schult-Kronefeld Olaf; Burkholder Iris; Goern Michael; Andritzky Birte; Blonski Katharina; Kugler Christian; Edler Lutz; Bokemeyer Carsten; Schumacher Udo; Laack Eckart
Lectin histochemistry of metastatic adenocarcinomas of the lung.
Lung cancer (Amsterdam, Netherlands) 2007;56(3):391-7.
2007: Hartmann Jörg Thomas; Pintoffl Jan Peter; Al-Batran Salah-Eddin; Quietzsch Detlef; Meisinger Ines; Horger Marius; Nehls Oliver; Bokemeyer Carsten; Königsrainer Alfred; Jäger Elke; Kanz Lothar
Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.
Onkologie 2007;30(5):235-40.
2007: Murga Penas Eva M; Callet-Bauchu Evelyne; Ye Hongtao; Hinz Kristina; Albert Nadine; Copie-Bergman Christiane; Gazzo Sophie; Berger Françoise; Salles Gilles; Bokemeyer Carsten; Du Ming-Qing; Dierlamm Judith
The translocations t(6;18;11)(q24;q21;q21) and t(11;14;18)(q21;q32;q21) lead to a fusion of the API2 and MALT1 genes and occur in MALT lymphomas.
Haematologica 2007;92(3):405-9.
2007: Langer Florian; Chun Felix Kyoung-Hwan; Amirkhosravi Ali; Friedrich Martin; Leuenroth Sven; Eifrig Barbara; Bokemeyer Carsten; Francis John L
Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
Thrombosis and haemostasis 2007;97(3):464-70.
2007: Oechsle Karin; Honecker Friedemann; Kollmannsberger Christian; Rick Oliver; Grünwald Victor; Mayer Frank; Hartmann Jörg T; Bokemeyer Carsten
An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors.
Anti-cancer drugs 2007;18(3):273-6.
2007: Atanackovic Djordje; Arfsten Julia; Cao Yanran; Gnjatic Sacha; Schnieders Frank; Bartels Katrin; Schilling Georgia; Faltz Christiane; Wolschke Christine; Dierlamm Judith; Ritter Gerd; Eiermann Thomas; Hossfeld Dieter Kurt; Zander Axel R; Jungbluth Achim A; Old Lloyd J; Bokemeyer Carsten; Kröger Nicolaus
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.
Blood 2007;109(3):1103-12.
2007: Balabanov Stefan; Gontarewicz Artur; Ziegler Patrick; Hartmann Ulrike; Kammer Winfried; Copland Mhairi; Brassat Ute; Priemer Martin; Hauber Ilona; Wilhelm Thomas; Schwarz Gerold; Kanz Lothar; Bokemeyer Carsten; Hauber Joachim; Holyoake Tessa L; Nordheim Alfred; Brümmendorf Tim H
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.
Blood 2007;109(4):1701-11.
2007: Wedding Ulrich; Honecker Friedemann; Bokemeyer Carsten; Pientka Ludger; Höffken Klaus
Tolerance to chemotherapy in elderly patients with cancer.
Cancer control : journal of the Moffitt Cancer Center 2007;14(1):44-56.
2007: Loges Sonja; Clausen Henning; Reichelt Uta; Bubenheim Michael; Erbersdobler Andreas; Schurr Paulus; Yekebas Emre; Schuch Gunter; Izbicki Jakob; Pantel Klaus; Bokemeyer Carsten; Fiedler Walter
Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):76-80.
2007: Bokemeyer C; Aapro M S; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
European journal of cancer (Oxford, England : 1990) 2007;43(2):258-70.
2006: Oechsle Karin; Müller Martin R; Hartmann Jörg T; Kanz Lothar; Bokemeyer Carsten
Aprepitant as salvage therapy in patients with chemotherapy-induced nausea and emesis refractory to prophylaxis with 5-HT(3) antagonists and dexamethasone.
Onkologie 2006;29(12):557-61.
2006: Loges Sonja; Tinnefeld Heike; Metzner Anja; Jücker Manfred; Butzal Martin; Bruweleit Melanie; Fischer Uta; Draab Elena; Schuch Gunter; O'-Farrel Anne Marie; Hossfeld Dieter Kurt; Bokemeyer Carsten; Fiedler Walter
Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416.
Leukemia & lymphoma 2006;47(12):2601-9.
2006: Langer Florian; Wintzer Hanns-Olof; Werner Mathias; Weber Christoph; Brümmendorf Tim H; Bokemeyer Carsten
A case of pulmonary carcinosarcoma (squamous cell carcinoma and osteosarcoma) treated with cisplatin and doxorubicin.
Anticancer research 2006;26(5B):3893-7.
2006: Kollmannsberger C; Honecker F; Bokemeyer C
Treatment of germ cell tumors--update 2006.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 10():x31-5.
2006: Atanackovic Djordje; Blum Inga; Cao Yanran; Wenzel Sören; Bartels Katrin; Faltz Christiane; Hossfeld Dieter Kurt; Hegewisch-Becker Susanna; Bokemeyer Carsten; Leuwer Rudolf
Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma.
Cancer biology & therapy 2006;5(9):1218-25.
2006: Murga Penas Eva M; Kawadler Holli; Siebert Reiner; Frank Matthias; Ye Hongtao; Hinz Kristina; Becher Claudia; Hummel Michael; Barth Thomas F E; Bokemeyer Carsten; Stein Harald; Trümper Lorenz; Möller Peter; Marynen Peter; Du Ming-Qing; Yang Xiaolu; Hansmann Martin L; Dierlamm Judith
A novel fusion of the MALT1 gene and the microtubule-associated protein 4 (MAP4) gene occurs in diffuse large B-cell lymphoma.
Genes, chromosomes & cancer 2006;45(9):863-73.
2006: Mueller Sandra; Schittenhelm Marcus; Honecker Friedemann; Malenke Elke; Lauber Kirsten; Wesselborg Sebastian; Hartmann Joerg T; Bokemeyer Carsten; Mayer Frank
Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
International journal of oncology 2006;29(2):471-9.
2006: Atanackovic Djordje; Schnee Benjamin; Schuch Gunter; Faltz Christiane; Schulze Julia; Weber Cora S; Schafhausen Philippe; Bartels Katrin; Bokemeyer Carsten; Brunner-Weinzierl Monika Christine; Deter Hans-Christian
Acute psychological stress alerts the adaptive immune response: stress-induced mobilization of effector T cells.
Journal of neuroimmunology 2006;176(1-2):141-52.
2006: Honecker Friedemann U; Brümmendorf Tim H; Klein Oliver; Bokemeyer Carsten
Safe use of oxaliplatin in a patient with metastatic breast cancer and combined renal and hepatic failure.
Onkologie 2006;29(6):273-5.
2006: Kollmannsberger C; Schittenhelm M; Honecker F; Tillner J; Weber D; Oechsle K; Kanz L; Bokemeyer C
A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(6):1007-13.
2006: Langer F; Amirkhosravi A; Ingersoll S B; Walker J M; Spath B; Eifrig B; Bokemeyer C; Francis J L
Experimental metastasis and primary tumor growth in mice with hemophilia A.
Journal of thrombosis and haemostasis : JTH 2006;4(5):1056-62.
2006: Andritzky Birte; Schuch Gunter; Thoem Ina; Goern Michael; Brandl Stephan; Bokemeyer Carsten; Laack Eckart
Long-term survival after second-line therapy with docetaxel and carboplatin and monthly pamidronic acid in a woman with metastatic non-small cell lung cancer.
Onkologie 2006;29(5):206-8.
2006: Hartmann J T; Oechsle K; Huober J; Jakob A; Azemar M; Horger M; Kanz L; Bokemeyer C
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma.
Investigational new drugs 2006;24(3):249-53.
2006: Kollmannsberger Christian; Nichols Craig; Bokemeyer Carsten
Recent advances in management of patients with platinum-refractory testicular germ cell tumors.
Cancer 2006;106(6):1217-26.
2006: Honecker Friedemann; Stoop Hans; Mayer Frank; Bokemeyer Carsten; Castrillon Diego H; Lau Yun-Fai Chris; Looijenga Leendert H J; Oosterhuis J Wolter
Germ cell lineage differentiation in non-seminomatous germ cell tumours.
The Journal of pathology 2006;208(3):395-400.
2006: Schittenhelm Marcus M; Shiraga Sharon; Schroeder Arin; Corbin Amie S; Griffith Diana; Lee Francis Y; Bokemeyer Carsten; Deininger Michael W N; Druker Brian J; Heinrich Michael C
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.
Cancer research 2006;66(1):473-81.
2006: Zivkovic Tijana; Chudoba Ilse; Bokemeyer Carsten; Dierlamm Judith
Multicolour banding provides a detailed characterisation of structural abnormalities of chromosome 1 in Burkitt lymphoma.
British journal of haematology 2006;132(1):2.
2006: Murga Penas Eva Maria; Hinz Kristina; Biller Laura; Zivkovic Tijana; Röser Kerstin; Löning Thomas; Parwaresch Reza; Bokemeyer Carsten; Dierlamm Judith
Frequency of chromosomal aneuploidies and deletions of the RB and TP53 genes in MALT lymphomas harboring the t(14;18)(q32;q21).
Cancer genetics and cytogenetics 2006;164(1):81-3.
2006: Cools Martine; Honecker Friedemann; Stoop Hans; Veltman Joris D; de Krijger Ronald R; Steyerberg Ewout; Wolffenbuttel Katja P; Bokemeyer Carsten; Lau Yun-Fai Chris; Drop Stenvert L S; Looijenga Leendert H J
Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumors.
Human pathology 2006;37(1):101-11.
2006: Barrett-Lee Peter J; Ludwig Heinz; Birgegård Gunnar; Bokemeyer Carsten; Gascón Pere; Kosmidis Paris A; Krzakowski Maciej; Nortier Johan W R; Kongable Gail; Schneider Maurice; Schrijvers Dirk; Van Belle Simon J;
Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey.
Oncology 2006;70(1):34-48.
2005: Bokemeyer Carsten
Is carboplatin as effective as radiotherapy for the adjuvant treatment of stage I seminoma?
Nature clinical practice. Urology 2005;2(12):586-7.
2005: Albers Peter; Albrecht Walter; Algaba Ferran; Bokemeyer Carsten; Cohn-Cedermark Gabriella; Horwich Alan; Klepp Olbjoern; Laguna M Pilar; Pizzocaro Giorgio
Guidelines on testicular cancer.
European urology 2005;48(6):885-94.
2005: Horstmann M; Merseburger A S; von der Heyde E; Serth J; Wegener G; Mengel M; Feil G; Hennenlotter J; Nagele U; Anastasiadis A; Bokemeyer C; Stenzl A; Kuczyk M
Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.
Journal of cancer research and clinical oncology 2005;131(11):715-22.
2005: Barrett-Lee Peter; Bokemeyer Carsten; Gascón Pere; Nortier J W R; Schneider Maurice; Schrijvers Dirk; Van Belle Simon;
Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey.
The oncologist 2005;10(9):743-57.
2005: Bokemeyer Carsten; Panse Jens
[Passive immunotherapy with monoclonal antibodies]
Onkologie 2005;28 Suppl 4():9-13.
2005: Holweger Karin; Bokemeyer Carsten; Lipp Hans-Peter
Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge.
Journal of cancer research and clinical oncology 2005;131(9):559-67.
2005: Hartmann Jörg Thomas; Rick Oliver; Oechsle Karin; Kuczyk Markus; Gauler Thomas; Schöffski Patrick; Schleicher Jan; Mayer Frank; Teichmann Reinhard; Kanz Lothar; Bokemeyer Carsten
Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors.
Annals of surgery 2005;242(2):260-6.
2005: Köhne C-H; van Cutsem E; Wils J; Bokemeyer C; El-Serafi M; Lutz M P; Lorenz M; Reichardt P; Rückle-Lanz H; Frickhofen N; Fuchs R; Mergenthaler H-G; Langenbuch T; Vanhoefer U; Rougier P; Voigtmann R; Müller L; Genicot B; Anak O; Nordlinger B;
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):4856-65.
2005: Schuch G; Oliveira-Ferrer L; Loges S; Laack E; Bokemeyer C; Hossfeld D K; Fiedler W; Ergun S
Antiangiogenic treatment with endostatin inhibits progression of AML in vivo.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(8):1312-7.
2005: Kollmannsberger C; Budach W; Stahl M; Schleucher N; Hehr T; Wilke H; Schleicher J; Vanhoefer U; Jehle E C; Oechsle K; Trarbach T; Boehlke I; Kanz L; Hartmann J T; Bokemeyer C
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(8):1326-33.
2005: Mayer Frank; Mueller Sandra; Malenke Elke; Kuczyk M; Hartmann Jörg T; Bokemeyer Carsten
Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines.
Investigational new drugs 2005;23(3):205-11.
2005: Stoop H; Honecker F; Cools M; de Krijger R; Bokemeyer C; Looijenga L H J
Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study.
Human reproduction (Oxford, England) 2005;20(6):1466-76.
2005: Kersemaekers Anne-Marie F; Honecker Friedemann; Stoop Hans; Cools Martine; Molier Michel; Wolffenbuttel Katja; Bokemeyer Carsten; Li Yunmin; Lau Yun-Fai Chris; Oosterhuis J Wolter; Looijenga Leendert H J
Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
Human pathology 2005;36(5):512-21.
2005: Hartmann Ulrike; Balabanov Stefan; Ziegler Patrick; Fellenberg Jörg; van der Kuip Heiko; Duyster Justus; Lipp Hans-Peter; Bokemeyer Carsten; Kanz Lothar; Brümmendorf Tim H
Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib.
Experimental hematology 2005;33(5):542-9.
2005: Becherer Alexander; De Santis Maria; Karanikas Georgios; Szabó Monica; Bokemeyer Carsten; Dohmen Bernhard M; Pont Jörg; Dudczak Robert; Dittrich Christian; Kletter Kurt
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals.
European journal of radiology 2005;54(2):284-8.
2005: Wierecky J; Kollmannsberger C; Boehlke I; Kuczyk M; Schleicher J; Schleucher N; Metzner B; Kanz L; Hartmann J T; Bokemeyer C
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Journal of cancer research and clinical oncology 2005;131(4):255-60.
2005: Kuczyk M; Wegener G; Merseburger A S; Anastasiadis A; Machtens S; Zumbrägel A; Hartmann J T; Bokemeyer C; Jonas Udo; Stenzl A
Impact of tumor size on the long-term survival of patients with early stage renal cell cancer.
World journal of urology 2005;23(1):50-4.
2005: Benoehr Peter; Krueth Patricia; Bokemeyer Carsten; Grenz Almut; Osswald Hartmut; Hartmann Jorg T
Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial.
Journal of the American Society of Nephrology : JASN 2005;16(2):452-8.
2005: Birgegård Gunnar; Bokemeyer Carsten
New guidelines on anaemia management in patients with cancer: How do these affect clinical practice?
Oncology 2005;69 Suppl 2():17-21.
2005: Birgegård Gunnar; Aapro Matti S; Bokemeyer Carsten; Dicato Mario; Drings Peter; Hornedo Javier; Krzakowski Maciej; Ludwig Heinz; Pecorelli Sergio; Schmoll Hans; Schneider Maurice; Schrijvers Dirk; Shasha Daniel; Van Belle Simon
Cancer-related anemia: pathogenesis, prevalence and treatment.
Oncology 2005;68 Suppl 1():3-11.
2005: Lipp Hans-Peter; Bokemeyer Carsten
[The action and toxicity of taxanes]
Pharmazie in unserer Zeit 2005;34(2):128-37.
2004: Honecker F; Wedding U; Bokemeyer C;
Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).
Onkologie 2004;27(6):583-8.
2004: Honecker F; Wedding U; Bokemeyer C;
Chemotherapy in elderly patients with advanced lung cancer. Part I: General aspects and treatment of small cell lung cancer (SCLC).
Onkologie 2004;27(5):500-5.
2004: Ludwig Heinz; Van Belle Simon; Barrett-Lee Peter; Birgegård Gunnar; Bokemeyer Carsten; Gascón Pere; Kosmidis Paris; Krzakowski Maciej; Nortier Johan; Olmi Patrizia; Schneider Maurice; Schrijvers Dirk
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.
European journal of cancer (Oxford, England : 1990) 2004;40(15):2293-306.
2004: Bokemeyer C; Aapro M S; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
European journal of cancer (Oxford, England : 1990) 2004;40(15):2201-16.
2004: Honecker Friedemann; Kersemaekers Anne-Marie F; Molier Michel; Van Weeren Pascale C; Stoop Hans; De Krijger Ronald R; Wolffenbuttel Katja P; Oosterhuis Wolter; Bokemeyer Carsten; Looijenga Leendert H J
Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development.
The Journal of pathology 2004;204(2):167-74.
2004: Rick O; Bokemeyer C; Weinknecht S; Schirren J; Pottek T; Hartmann J T; Braun T; Rachud B; Weissbach L; Hartmann M; Siegert W; Beyer J
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3713-9.
2004: Bokemeyer C; Kollmannsberger C; Stenning S; Hartmann J T; Horwich A; Clemm C; Gerl A; Meisner C; Rückerl C-P; Schmoll H-J; Kanz L; Oliver T
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
British journal of cancer 2004;91(4):683-7.
2004: Hofheinz R-D; Hartmann J T; Willer A; Oechsle K; Hartung G; Gnad U; Saussele S; Kreil S; Bokemeyer C; Hehlmann R; Hochhaus A
Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial.
British journal of cancer 2004;91(5):834-8.
2004: Schenk Paul W; Stoop Hans; Bokemeyer Carsten; Mayer Frank; Stoter Gerrit; Oosterhuis J Wolter; Wiemer Erik; Looijenga Leendert H J; Nooter Kees
Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1.
Neoplasia (New York, N.Y.) 2004;6(4):297-301.
2004: Honecker Friedemann; Stoop Hans; de Krijger Ronald R; Chris Lau Yun-Fai; Bokemeyer Carsten; Looijenga Leendert H J
Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells.
The Journal of pathology 2004;203(3):849-57.
2004: Bokemeyer Carsten; Foubert Jan
Anemia impact and management: focus on patient needs and the use of erythropoietic agents.
Seminars in oncology 2004;31(3 Suppl 8):4-11.
2004: Hartmann Joerg Thomas; Oechsle Karin; Jäger Elke; Reis Hans Edgar; Haag Cornelie; Niederle Norbert; Wilke Hans-Joachim; Pflüger Karl-Heinz; Batran Salah Al; Büchele Thomas; Hofheinz Ralf D; Kanz Lothar; Bokemeyer Carsten
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil.
Anti-cancer drugs 2004;15(5):473-7.
2004: Pfannenberg Anna C; Oechsle Karin; Bokemeyer Carsten; Kollmannsberger Christian; Dohmen Bernhard M; Bares Roland; Hartmann Jörg T; Vonthein Reinhard; Claussen Claus D
The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management.
World journal of urology 2004;22(2):132-9.
2004: Kuczyk M A; Bokemeyer C; Kollmannsberger C; Corvin S; Anastasiadis A; Machtens S; Merseburger A; Wegener G; Stenze A; Hartmann J T; Jonas U
Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience.
World journal of urology 2004;22(1):55-9.
2004: Honecker Friedemann; Oosterhuis J Wolter; Mayer Frank; Hartmann Jörg Thomas; Bokemeyer Carsten; Looijenga Leendert H J
New insights into the pathology and molecular biology of human germ cell tumors.
World journal of urology 2004;22(1):15-24.
2004: Rick O; Kollmannsberger C; Hartmann J T; Braun T; Siegert W; Bokemeyer C; Beyer J
The role of high-dose chemotherapy in relapsed germ cell tumors.
World journal of urology 2004;22(1):25-32.
2004: Bokemeyer Carsten; Littlewood Tim; Aapro Matti
Is once-weekly epoetin beta 'highly effective' in treating anaemia in patients with lymphoproliferative malignancy?
British journal of haematology 2004;125(1):98-9; author reply 99-100.
2004: De Santis Maria; Becherer Alexander; Bokemeyer Carsten; Stoiber Franz; Oechsle Karin; Sellner Franz; Lang Alois; Kletter Kurt; Dohmen Bernhard M; Dittrich Christian; Pont Jörg
2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1034-9.
2004: Pfannenberg A C; Oechsle K; Kollmannsberger C; Dohmen B M; Bokemeyer C; Bares R; Vontheim R; Claussen C D
[Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2004;176(1):76-84.
2004: Kollmannsberger C; Beyer J; Liersch R; Schoeffski P; Metzner B; Hartmann J T; Rick O; Stengele K; Hohloch K; Spott C; Kanz L; Bokemeyer C
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):108-14.
2003: Merseburger A S; Wegener G; Horstmann M; Oelke M; Zumbrägel A; Bokemeyer C; Kollmannsberger C; Jonas U; Stenzl A; Kuczyk M
[Impact of tumor size on long-term survival of patients with organ-confined renal cell cancer]
Aktuelle Urologie 2003;34(7):469-74.
2003: Koch S; Mayer F; Honecker F; Schittenhelm M; Bokemeyer C
Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro.
British journal of cancer 2003;89(11):2133-9.
2003: Hartmann J T; Oechsle K; Quietzsch D; Wein A; Hofheinz R D; Honecker F; Nehls O; Köhne C-H; Käfer G; Kanz L; Bokemeyer C
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study.
British journal of cancer 2003;89(11):2051-6.
2003: Reichardt Peter; Oechsle Karin; Pink Daniel; Bokemeyer Carsten; Schneller F; Issels Rolf; Kanz Lothar; Hartmann Jörg Thomas
An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma.
Investigational new drugs 2003;21(4):481-6.
2003: Schmoll H-J; Kollmannsberger C; Metzner B; Hartmann J T; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel W E; Andreesen R; Bokemeyer C;
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4083-91.
2003: Honecker Friedemann; Mayer Frank; Stoop Hans; Oosterhuis J Wolter; Koch Sandra; Bokemeyer Carsten; Looijenga Leendert H J
Xeroderma pigmentosum group a protein and chemotherapy resistance in human germ cell tumors.
Laboratory investigation; a journal of technical methods and pathology 2003;83(10):1489-95.
2003: Köhne C-H; Wils J; Lorenz M; Schöffski P; Voigtmann R; Bokemeyer C; Lutz M; Kleeberg C; Ridwelski K; Souchon R; El-Serafi M; Weiss U; Burkhard O; Rückle H; Lichnitser M; Langenbuch T; Scheithauer W; Baron B; Couvreur M L; Schmoll H J;
Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3721-8.
2003: Rick O; Kollmannsberger C; Beyer J; Bokemeyer C
Current aspects of high-dose chemotherapy in germ-cell tumors.
Critical reviews in oncology/hematology 2003;47(3):237-48.
2003: Bokemeyer C; Schleucher N; Metzner B; Thomas M; Rick O; Schmoll H-J; Kollmannsberger C; Boehlke I; Kanz L; Hartmann J T
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial.
British journal of cancer 2003;89(1):29-35.
2003: Mayer Frank; Stoop Hans; Sen Subrata; Bokemeyer Carsten; Oosterhuis J Wolter; Looijenga Leendert H J
Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes.
Oncogene 2003;22(25):3859-66.
2003: Mayer F; Honecker F; Looijenga L H J; Bokemeyer C
Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(6):825-32.
2003: Brummendorf Tim H; Ersoz Inci; Hartmann Ulrike; Balabanov Stefan; Wolke Holger; Paschka Peter; Lahaye Tanja; Berner Birgit; Bartolovic Kerol; Kreil Sebastian; Berger Ute; Gschaidmeier Harald; Bokemeyer Carsten; Hehlmann Rudiger; Dietz Klaus; Lansdorp Peter M; Kanz Lothar; Hochhaus Andreas
Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia.
Annals of the New York Academy of Sciences 2003;996():26-38.
2003: Looijenga Leendert H J; Stoop Hans; de Leeuw Hubert P J C; de Gouveia Brazao Carlos A; Gillis Ad J M; van Roozendaal Kees E P; van Zoelen Everardus J J; Weber Rob F A; Wolffenbuttel Katja P; van Dekken Herman; Honecker Friedemann; Bokemeyer Carsten; Perlman Elizabeth J; Schneider Dominik T; Kononen Juha; Sauter Guido; Oosterhuis J Wolter
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.
Cancer research 2003;63(9):2244-50.
2003: Wedding Ulrich; Bokemeyer Carsten; Meran Johannes Gobertus;
[Elderly patients with acute myeloid leukemia: characteristics in biology, patients, and treatment]
Medizinische Klinik (Munich, Germany : 1983) 2003;98(4):193-207.
2003: Weinmann Martin; Jeremic Branislav; Bamberg Michael; Bokemeyer Carsten
Treatment of lung cancer in elderly part II: small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;40(1):1-16.
2003: Kollmannsberger C; Schleucher N; Rick O; Metzner B; Hartmann J T; Schöffski P; Beyer J; Casper J; Sosada M; Schmoll H-J; Böhlke I; Meisner C; Kanz L; Bokemeyer C
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support.
European journal of cancer (Oxford, England : 1990) 2003;39(6):775-82.
2003: Hartmann J T; Oechsle K; Mayer F; Kanz L; Bokemeyer C
Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas.
Anticancer research 2003;23(2C):1899-901.
2003: Kuczyk M; Münch T; Bokemeyer C; Merseburger A; Wefer A; Kollmannsberger C; Kondoh M; Wegener G; Jonas U; Stenzl A
[Is adrenalectomy an indispensable part of nephrectomy? Results of a multivariate statistical analysis]
Der Urologe. Ausg. A 2003;42(3):366-73.
2003: Mayer Frank; Stoop Hans; Scheffer George L; Scheper Rik; Oosterhuis J Wolter; Looijenga Leendert H J; Bokemeyer Carsten
Molecular determinants of treatment response in human germ cell tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):767-73.
2003: Bokemeyer Carsten; Hartmann Jorg T; Fossa Sophie D; Droz Jean-P; Schmol Hans-J; Horwich Alan; Gerl Arthur; Beyer Jorg; Pont Jorg; Kanz Lothar; Nichols Craig R; Einhorn Lawrence
Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(1):49-59; discussion 59-63.
2003: Brümmendorf Tim H; Ersöz Inci; Hartmann Ulrike; Bartolovic Kerol; Balabanov Stefan; Wahl Alexandra; Paschka Peter; Kreil Sebastian; Lahaye Tanja; Berger Ute; Gschaidmeier Harald; Bokemeyer Carsten; Hehlmann Rüdiger; Dietz Klaus; Lansdorp Peter M; Kanz Lothar; Hochhaus Andreas
Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia.
Blood 2003;101(1):375-6.
2003: Merseburger Axel S; Kuczyk Markus A; Serth Jurgen; Bokemeyer Carsten; Young Denise Y; Sun Leon; Connelly Roger R; McLeod David G; Mostofi Fathollah K; Srivastava Shiv K; Stenzl A; Moul Judd W; Sesterhenn Isabell A
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues.
Oncology reports 2003;10(1):223-8.
2003: Martin Silas C; Gagnon Dennis D; Zhang Lucy; Bokemeyer Carsten; Van Marwijk Kooy Marinus; van Hout Ben
Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer.
PharmacoEconomics 2003;21(16):1153-69.
2003: Honecker Friedemann; Köhne Claus-Henning; Bokemeyer Carsten
Colorectal cancer in the elderly: is palliative chemotherapy of value?
Drugs & aging 2003;20(1):1-11.
2002: Bokemeyer C; Oechsle K; Hartmann J T; Schöffski P; Schleucher N; Metzner B; Schleicher J; Kanz L
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer.
British journal of cancer 2002;87(10):1066-71.
2002: Bokemeyer C; Kanz L
[Allogeneic hematopoetic cell transplantation in patients with solid tumors - Contra]
Deutsche medizinische Wochenschrift (1946) 2002;127(42):2215.
2002: Kollmannsberger C; Rick O; Klaproth H; Kubin T; Sayer H G; Hentrich M; Welslau M; Mayer F; Kuczyk M; Spott C; Kanz L; Bokemeyer C
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
British journal of cancer 2002;87(7):729-32.
2002: Hartmann J T; Nichols C R; Droz J-P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Kanz L; Einhorn L; Bokemeyer C
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1017-28.
2002: Kollmannsberger C; Mayer F; Pressler H; Koch S; Kanz L; Oosterhuis J W; Looijenga L H J; Bokemeyer C
Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer.
Cancer 2002;95(2):301-8.
2002: Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann J T; Baronius W; Hempel V; Kanz L; Bokemeyer C
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Anti-cancer drugs 2002;13(5):497-503.
2002: Mayer F; Hartmann J T; von Pawel J; Beck J; Schroeder M; Boehlke I; Kanz L; Bokemeyer C;
A phase I study of oral uracil-ftorafur plus folinic acid in combination with weekly paclitaxel in patients with solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(5):755-9.
2002: Mayer Frank; Gillis Ad J M; Dinjens Winand; Oosterhuis J Wolter; Bokemeyer Carsten; Looijenga Leendert H J
Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment.
Cancer research 2002;62(10):2758-60.
2002: Kollmannsberger Christian; Oechsle Karin; Dohmen Bernhard M; Pfannenberg Anna; Bares Roland; Claussen Claus D; Kanz Lothar; Bokemeyer Carsten
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
Cancer 2002;94(9):2353-62.
2002: Jakob A; Bokemeyer C; Knop S; Schupp M; Mayer F; Kanz L
Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation--a phase II study.
Anti-cancer drugs 2002;13(4):405-10.
2002: Kollmannsberger C; Rick O; Derigs H-G; Schleucher N; Schöffski P; Beyer J; Schoch R; Sayer H G; Gerl A; Kuczyk M; Spott C; Kanz L; Bokemeyer C
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2031-7.
2002: Kuczyk M; Münch T; Machtens S; Bokemeyer C; Wefer A; Hartmann J; Kollmannsberger C; Kondo M; Jonas U
The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience.
BJU international 2002;89(6):517-22.
2002: Bokemeyer Carsten; Nichols Craig R; Droz Jean-P; Schmoll Hans-J; Horwich Alan; Gerl Arthur; Fossa Sophie D; Beyer Jörg; Pont Jörg; Kanz Lothar; Einhorn Lawrence; Hartmann Jörg T
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1864-73.
2002: Kersemaekers Anne-Marie F; Mayer Frank; Molier Michel; van Weeren Pascale C; Oosterhuis J Wolter; Bokemeyer Carsten; Looijenga Leendert H J
Role of P53 and MDM2 in treatment response of human germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1551-61.
2002: Bokemeyer C; Honecker F; Wedding U; Späth-Schwalbe E; Lipp H P; Kolb G;
Use of hematopoietic growth factors in elderly patients receiving cytotoxic chemotherapy.
Onkologie 2002;25(1):32-9.
2002: Bokemeyer C; Kollmannsberger C; Oechsle K; Dohmen B M; Pfannenberg A; Claussen C D; Bares R; Kanz L
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET.
British journal of cancer 2002;86(4):506-11.
2002: Honecker F; Kolb G; Bokemeyer C
[Therapy of elderly patients with colorectal carcinoma]
Wiener medizinische Wochenschrift (1946) 2002;152(7-8):170-6.
2001: Hartmann J T; Fossa S D; Nichols C R; Droz J P; Horwich A; Gerl A; Beyer J; Pont J; Fizazi K; Hecker H; Kanz L; Einhorn L; Bokemeyer C
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
Journal of the National Cancer Institute 2001;93(22):1733-8.
2001: Kuczyk M A; Bokemeyer C; Hartmann J; Schubach J; Walter C; Machtens S; Knuchel R; Kollmannsberger C; Jonas U; Serth J
Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer.
Oncology reports 2001;8(6):1401-7.
2001: Dittmann H; Sokler M; Kollmannsberger C; Dohmen B M; Baumann C; Kopp A; Bares R; Claussen C D; Kanz L; Bokemeyer C
Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma.
Oncology reports 2001;8(6):1393-9.
2001: De Santis M; Bokemeyer C; Becherer A; Stoiber F; Oechsle K; Kletter K; Dohmen B M; Dittrich C; Pont J
Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(17):3740-4.
2001: Machtens S; Serth J; Bokemeyer C; Bathke W; Minssen A; Kollmannsberger C; Hartmann J; Knüchel R; Kondo M; Jonas U; Kuczyk M
Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features.
International journal of cancer. Journal international du cancer 2001;95(5):337-42.
2001: Genvresse I; Wedding U; Bokemeyer C; Späth-Schwalbe E
[Treatment of multiple myeloma in elderly patients: consensus of the Geriatric Oncology Working Group of the German Society of Hematologic Oncology and the German Society of Geriatrics]
Onkologie 2001;24(4):386-90.
2001: Bokemeyer C; Gillis A J; Pompe K; Mayer F; Metzner B; Schleucher N; Schleicher J; Pflugrad-Jauch G; Oosterhuis J W; Kanz L; Looijenga L H
Clinical impact of germ cell tumor cells in apheresis products of patients receiving high-dose chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):3029-36.
2001: Fizazi K; Tjulandin S; Salvioni R; Germà-Lluch J R; Bouzy J; Ragan D; Bokemeyer C; Gerl A; Fléchon A; de Bono J S; Stenning S; Horwich A; Pont J; Albers P; De Giorgi U; Bower M; Bulanov A; Pizzocaro G; Aparicio J; Nichols C R; Théodore C; Hartmann J T; Schmoll H J; Kaye S B; Culine S; Droz J P; Mahé C
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2647-57.
2001: Kollmannsberger C; Mayer F; Kuczyk M; Kanz L; Bokemeyer C
Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy.
World journal of urology 2001;19(2):120-5.
2001: Bokemeyer C; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Schmoll H J; Kanz L; Einhorn L; Nichols C R; Hartmann J T
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
Cancer 2001;91(7):1394-401.
2001: Hartmann J T; Einhorn L; Nichols C R; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Schmoll H J; Kanz L; Bokemeyer C
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1641-8.
2001: Honecker F; Wedding U; Kolb G; Bokemeyer C
[Chemotherapy of colorectal cancer--which therapy is justified for elderly patients?]
Onkologie 2001;24(1):87-94.
2001: Hartmann J T; von Vangerow A; Fels L M; Knop S; Stolte H; Kanz L; Bokemeyer C
A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation.
British journal of cancer 2001;84(3):313-20.
2001: Rick O; Bokemeyer C; Beyer J; Hartmann J T; Schwella N; Kingreen D; Neureither S; Metzner B; Casper J; Wandt H; Hartmann F; Schmoll H J; Derigs G; Gerl A; Berdel W E; Kanz L; Siegert W
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):81-8.
2000: Bokemeyer C; Hartmann J T; Mayer F; Böhlke I; Kanz L; Von Pawel J; Derigs G; Schröder M
UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors.
Oncology (Williston Park, N.Y.) 2000;14(10 Suppl 9):63-7.
2000: Roelofs H; Mostert M C; Pompe K; Zafarana G; van Oorschot M; van Gurp R J; Gillis A J; Stoop H; Beverloo B; Oosterhuis J W; Bokemeyer C; Looijenga L H
Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis.
The American journal of pathology 2000;157(4):1155-66.
2000: Hartmann J T; Fels L M; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Anticancer research 2000;20(5C):3767-73.
2000: Kollmannsberger C; Nichols C; Meisner C; Mayer F; Kanz L; Bokemeyer C
Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(9):1115-20.
2000: Souchon R; Krege S; Schmoll H J; Albers P; Beyer J; Bokemeyer C; Classen J; Dieckmann K P; Hartmann M; Heidenreich A; Höltl W; Kliesch S; Köhrmann K U; Kuczyk M; Schmidberger H; Weinknecht S; Winter E; Wittekind C; Bamberg M
[Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG)]
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(9):388-405.
2000: Kuczyk M; Machtens S; Bokemeyer C; Schultheiss D; Jonas U
Sexual function and fertility after treatment of testicular cancer.
Current opinion in urology 2000;10(5):473-7.
2000: Kollmannsberger C; Gerl A; Schleucher N; Beyer J; Kuczyk M; Rick O; Casper J; Sosada M; Rie C; Kanz L; Bokemeyer C
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer.
Anti-cancer drugs 2000;11(7):535-9.
2000: Hartmann J T; Fels L M; Knop S; Stolt H; Kanz L; Bokemeyer C
A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors.
Investigational new drugs 2000;18(3):281-9.
2000: Kollmannsberger C; Quietzsch D; Haag C; Lingenfelser T; Schroeder M; Hartmann J T; Baronius W; Hempel V; Clemens M; Kanz L; Bokemeyer C
A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
British journal of cancer 2000;83(4):458-62.
2000: Hartmann J T; Nichols C R; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Einhorn L; Kanz L; Bokemeyer C
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors.
Cancer 2000;88(11):2629-35.
2000: Kollmannsberger C; Nichols C; Bamberg M; Hartmann J T; Schleucher N; Beyer J; Schöfski P; Derigs G; Rüther U; Böhlke I; Schmoll H J; Kanz L; Bokemeyer C
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(5):553-9.
2000: Hartmann J T; Kanz L; Bokemeyer C
Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma.
Anticancer research 2000;20(2B):1177-82.
2000: Hartmann J T; Knop S; Fels L M; van Vangerow A; Stolte H; Kanz L; Bokemeyer C
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors.
Anti-cancer drugs 2000;11(1):1-6.
2000: Hartmann J T; Nichols C R; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Fizazi K; Einhorn L; Kanz L; Bokemeyer C
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors.
Journal of the National Cancer Institute 2000;92(1):54-61.
2000: Bokemeyer C; Kollmannsberger C; Hartmann J T; Kanz L
Follow up after primary treatment: curable diseases treated non-surgically.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 3():73-8.
1999: Hartmann J T; Kollmannsberger C; Kanz L; Bokemeyer C
Platinum organ toxicity and possible prevention in patients with testicular cancer.
International journal of cancer. Journal international du cancer 1999;83(6):866-9.
1999: Kollmannsberger C; Hartmann J T; Kanz L; Bokemeyer C
Therapy-related malignancies following treatment of germ cell cancer.
International journal of cancer. Journal international du cancer 1999;83(6):860-3.
1999: Bokemeyer C; Kollmannsberger C; Harstrick A; Beyer J; Gerl A; Casper J; Metzner B; Hartmann J T; Schmoll H J; Kanz L
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG).
International journal of cancer. Journal international du cancer 1999;83(6):848-51.
1999: Kollmannsberger C; Kuzcyk M; Mayer F; Hartmann J T; Kanz L; Bokemeyer C
Late toxicity following curative treatment of testicular cancer.
Seminars in surgical oncology 1999;17(4):275-81.
1999: Kollmannsberger C; Pressler H; Mayer F; Kanz L; Bokemeyer C
Cisplatin-refractory, HER2/neu-expressing germ-cell cancer: induction of remission by the monoclonal antibody Trastuzumab.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1393-4.
1999: Kuczyk M; Machtens S; Hradil K; Schubach J; Christian W; Knüchel R; Hartmann J; Bokemeyer C; Jonas U; Serth J
Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.
British journal of cancer 1999;81(6):1052-8.
1999: Bokemeyer C; Kollmannsberger C; Meisner C; Harstrick A; Beyer J; Metzner B; Hartmann J T; Schmoll H J; Einhorn L; Kanz L; Nichols C
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3450-6.
1999: Hartmann J T; Kuczyk M A; Kollmannsberger C; Kanz L; Bokemeyer C
Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer.
World journal of urology 1999;17(5):324-33.
1999: Hartmann J T; Quietzsch D; Daikeler T; Kollmannsberger C; Mayer F; Kanz L; Bokemeyer C
Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer.
Anti-cancer drugs 1999;10(8):729-33.
1999: Machtens S; Kuczyk M; Becker A J; Bokemeyer C; Serth J; Jonas U
[New aspects on the identification of genetic alterations and prognostically important biological parameters in renal cell cancer]
Der Urologe. Ausg. A 1999;38(5):442-51.
1999: Hartmann J T; Kanz L; Bokemeyer C
Diagnosis and treatment of patients with testicular germ cell cancer.
Drugs 1999;58(2):257-81.
1999: Bokemeyer C; Hartmann J T; Kollmannsberger C; Mayer F; Kanz L
UFT/calcium folinate plus weekly paclitaxel for solid tumors.
Oncology (Williston Park, N.Y.) 1999;13(7 Suppl 3):106-11.
1999: Kollmannsberger C; Brugger W; Hartmann J T; Maurer F; Böhm P; Kanz L; Bokemeyer C
Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma.
Anti-cancer drugs 1999;10(5):453-6.
1999: Hartmann J T; Albrecht C; Schmoll H J; Kuczyk M A; Kollmannsberger C; Bokemeyer C
Long-term effects on sexual function and fertility after treatment of testicular cancer.
British journal of cancer 1999;80(5-6):801-7.
1999: Kuczyk M A; Machtens S; Bokemeyer C; Hradil K; Macheel I; Jetscho V; Hartmann J; Thon W F; Jonas U; Serth J
Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancer.
Oncology reports 1999;6(3):687-93.
1999: Kuczyk M; Serth J; Bokemeyer C; Machtens S; Schwede J; Herrmann R; Paeslack U; Truss M C; Knüchel R; Jonas U
The need for microdissectional tumor cell preparation during the molecular genetic analysis of prostate cancer.
World journal of urology 1999;17(2):115-22.
1999: Hartmann J T; Bokemeyer C
Chemotherapy for renal cell carcinoma.
Anticancer research 1999;19(2C):1541-3.
1999: Fosså S D; Bokemeyer C; Gerl A; Culine S; Jones W G; Mead G M; Germa-Luch J R; Pont J; Schmoll H J; Tjulandin S
Treatment outcome of patients with brain metastases from malignant germ cell tumors.
Cancer 1999;85(4):988-97.
1999: Bokemeyer C; Gerl A; Schöffski P; Harstrick A; Niederle N; Beyer J; Casper J; Schmoll H J; Kanz L
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):512-6.
1999: Serth J; Kuczyk M; Machtens S; Bokemeyer C; Herrmann R; Hartmann J; Knüchel R; Jonas U
Analysis of the cyclin-dependent kinase inhibitor p27Kip1 in muscle invasive bladder cancer.
Oncology reports 1999;6(1):229-33.
1999: Kollmannsberger C; Mross K; Jakob A; Kanz L; Bokemeyer C
Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experience.
Oncology 1999;56(1):1-12.
1998: Jakob A; Kollmannsberger C; Kanz L; Bokemeyer C
[Late toxicity after chemotherapy of malignant testicular tumors]
Der Urologe. Ausg. A 1998;37(6):635-47.
1998: Kollmannsberger C; Beyer J; Droz J P; Harstrick A; Hartmann J T; Biron P; Fléchon A; Schöffski P; Kuczyk M; Schmoll H J; Kanz L; Bokemeyer C
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3386-91.
1998: Hartmann J T; Köhne C H; Schmoll H J; Daikeler T; Kanz L; Bokemeyer C
Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
Oncology 1998;55(4):320-5.
1998: Hartmann J T; Harstrick A; Daikeler T; Kollmannsberger C; Müller C; Seeber S; Kanz L; Bokemeyer C
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancer.
Anti-cancer drugs 1998;9(5):427-31.
1998: Kuczyk M A; Köhn G; Höfner K; Machtens S; Bokemeyer C; Stief C G; Truss M C; Schäfers H J; Hartmann J T; Jonas U
[Prognostic relevance of vena cava thrombosis in renal cell carcinoma]
Der Urologe. Ausg. A 1998;37(3):299-305.
1998: Bokemeyer C
Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
Oncology 1998;55(3):177-88.
1998: Kuczyk M A; Serth J; Bokemeyer C; Machtens S; Minssen A; Bathke W; Hartmann J; Jonas U
The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy.
European journal of cancer (Oxford, England : 1990) 1998;34(5):679-86.
1998: Bokemeyer C; Berger C C; Hartmann J T; Kollmannsberger C; Schmoll H J; Kuczyk M A; Kanz L
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
British journal of cancer 1998;77(8):1355-62.
1998: Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann J T; Holstein K; Derigs H G; de Wit R; Casper J; Schöffski P; Kührer I; Illiger H J; Kempf B; Reichle A; Föller A; Hossfeld D K; Fischer J T; Berdel W E; Gerhartz H H; Kirchner H; Pflüger K H; Ostermann H; Kanz L; Schmoll H J
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Seminars in oncology 1998;25(2 Suppl 4):24-32; discussion 45-8.
1998: Kuczyk M; Serth J; Machtens S; Bokemeyer C; Bathke W; Stief C; Jonas U
Expression of E-cadherin in primary prostate cancer: correlation with clinical features.
British journal of urology 1998;81(3):406-12.
1998: Hartmann J T; Schmoll E; Bokemeyer C; Fety R; Lucas C; Giroux B; Schmoll H J
Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastases.
European journal of cancer (Oxford, England : 1990) 1998;34(1):87-91.
1998: Kuczyk M A; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
Oncology reports 1998;5(1):213-6.
1998: Bokemeyer C; Hartmann J T; Kuczyk M A; Truss M C; Kollmannsberger C; Beyer J; Jonas U; Kanz L
Recent strategies for the use of paclitaxel in the treatment of urological malignancies.
World journal of urology 1998;16(2):155-62.
1998: Kollmannsberger C; Hartmann J T; Kanz L; Bokemeyer C
Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
Journal of cancer research and clinical oncology 1998;124(3-4):207-14.
1997: Pont J; Bokemeyer C; Harstrick A; Sellner F; Greinix H; Stoiber F
Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: a retrospective multicenter study of the Austrian Study Group on Urologic Oncology.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1229-34.
1997: Bokemeyer C; Hartmann J T; Lampe C S; Clemens M R; Quietzsch D; Forkmann L; Kanz L
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
Seminars in oncology 1997;24(6 Suppl 19):S19-96-S19-100.
1997: Bokemeyer C; Franzke A; Hartmann J T; Schöber C; Arseniev L; Metzner B; Link H; Kanz L; Schmoll H J
A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.
Cancer 1997;80(7):1221-7.
1997: Bamberg M; Schmoll H J; Weissbach L; Beyer J; Bokemeyer C; Harstrick A; Höltl W; Souchon R; Vogler H
[An interdisciplinary consensus conference on the diagnosis and therapy of testicular tumors]
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1997;173(8):397-406.
1997: Daikeler T; Maas K; Hartmann J T; Kanz L; Bokemeyer C
Weekly short infusions of gemcitabine are not associated with suppression of lymphatic activity in patients with solid tumors.
Anti-cancer drugs 1997;8(6):643-4.
1997: Kuczyk M A; Bokemeyer C; Köhn G; Stief C G; Machtens S; Truss M; Höfner K; Jonas U
Prognostic relevance of intracaval neoplastic extension for patients with renal cell cancer.
British journal of urology 1997;80(1):18-24.
1997: Hartmann J T; Schmoll H J; Kuczyk M A; Candelaria M; Bokemeyer C
Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(6):531-8.
1997: Hartmann J T; Candelaria M; Kuczyk M A; Schmoll H J; Bokemeyer C
Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
European journal of cancer (Oxford, England : 1990) 1997;33(6):843-7.
1997: Bokemeyer C; Nowak P; Haupt A; Metzner B; Köhne H; Hartmann J T; Kanz L; Schmoll H J
Treatment of brain metastases in patients with testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1449-54.
1997: Bokemeyer C; Lampe C S; Clemens M R; Hartmann J T; Quietzsch D; Forkmann L; Kollmannsberger C; Kanz L
A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer.
Anti-cancer drugs 1997;8(4):396-9.
1997: Köhne C H; Wilke H; Hiddemann W; Bokemeyer C; Lohrmann H P; Bodenstein H; Preiss J; Rauschecker H; Hill H; Kaufer C; Fischer J T; Ohl U; Urbanitz D; Balleisen L; Schmoll H J
Phase II evaluation of 5-fluourouracil plus folinic acid and alpha 2b-interferon in metastatic colorectal cancer.
Oncology 1997;54(2):96-101.
1997: Dunn T A; Schmoll H J; Grünwald V; Bokemeyer C; Casper J
Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines.
Investigational new drugs 1997;15(2):109-14.
1997: Dunn T A; Grünwald V; Bokemeyer C; Casper J
Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenografts.
Investigational new drugs 1997;15(2):91-8.
1996: Bokemeyer C; Köhrmann O; Tischler J; Weissbach L; Räth U; Haupt A; Schöffski P; Harstrick A; Schmoll H J
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(10):1015-21.
1996: Bokemeyer C; Fels L M; Dunn T; Voigt W; Gaedeke J; Schmoll H J; Stolte H; Lentzen H
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.
British journal of cancer 1996;74(12):2036-41.
1996: Bokemeyer C; Kuczyk M A; Köhne C H; Haupt A; Schmoll H J
[Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis]
Medizinische Klinik (Munich, Germany : 1983) 1996;91(11):703-10.
1996: Bokemeyer C; Berger C C; Kuczyk M A; Schmoll H J
Evaluation of long-term toxicity after chemotherapy for testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):2923-32.
1996: Kuczyk M A; Serth J; Bokemeyer C; Jonassen J; Machtens S; Werner M; Jonas U
Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis.
Cancer 1996;78(9):1958-66.
1996: Beyer J; Kramar A; Mandanas R; Linkesch W; Greinix A; Droz J P; Pico J L; Diehl A; Bokemeyer C; Schmoll H J; Nichols C R; Einhorn L H; Siegert W
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2638-45.
1996: Dunn T A; Schmoll H J; Grünwald V; Bokemeyer C; Casper J
Amifostine does not alter the antitumor activity of cisplatin in a pre-clinical model of testicular cancer.
Anti-cancer drugs 1996;7(7):795-9.
1996: Maas K; Daikeler T; Kanz L; Bokemeyer C
Activity of gemcitabine in platinum-resistant ovarian germ cell cancer.
European journal of cancer (Oxford, England : 1990) 1996;32A(8):1437-8.
1996: Berger C C; Bokemeyer C; Schuppert F; Schmoll H J
Endocrinological late effects after chemotherapy for testicular cancer.
British journal of cancer 1996;73(9):1108-14.
1996: Hebart H; Erley C; Kaskas B; Mayer R; König M; Einsele H; Bokemeyer C; Meerpohl H G; Feine U; Kanz L
Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(4):416-8.
1996: Bokemeyer C
[Late damage of curative oncologic therapy. Results of a patient sample with Hodgkin's disease and testicular tumors at the Hannover Medical School]
Medizinische Klinik (Munich, Germany : 1983) 1996;91 Suppl 3():60-7.
1996: Bokemeyer C; Beyer J; Metzner B; Ruther U; Harstrick A; Weissbach L; Kohrmann U; Verbeek W; Schmoll H J
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(1):31-4.
1996: Kuczyk M A; Bokemeyer C; Serth J; Machtens S; Höfner K; Jonas U
[Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status]
Der Urologe. Ausg. A 1996;35(1):35-45.
1996: Bokemeyer C; Thon W F; Brunkhorst T; Kuczyk M A; Pichlmayr R; Kleim V
High frequency of urothelial cancers in patients with kidney transplantations for end-stage analgesic nephropathy.
European journal of cancer (Oxford, England : 1990) 1996;32A(1):175-6.
1996: Gaedeke J; Fels L M; Bokemeyer C; Mengs U; Stolte H; Lentzen H
Cisplatin nephrotoxicity and protection by silibinin.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(1):55-62.
1996: Bokemeyer C; Kuczyk M A; Köhne H; Einsele H; Kynast B; Schmoll H J
Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy.
Annals of hematology 1996;72(1):1-9.
1996: Fels L M; Bokemeyer C; van Rhee J; Schmoll H J; Stolte H
Evaluation of late nephrotoxicity in long-term survivors of Hodgkin's disease.
Oncology 1996;53(1):73-8.
1996: Bokemeyer C; Hartmann J T; Kuczyk M A; Truss M C; Beyer J; Jonas U; Kanz L
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors.
World journal of urology 1996;14(6):354-9.
1996: Bokemeyer C; Kuczyk M A; Serth J; Hartmann J T; Schmoll H J; Jonas U; Kanz L
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters.
Journal of cancer research and clinical oncology 1996;122(10):575-84.
1996: Bokemeyer C; Kuczyk M A; Dunn T; Serth J; Hartmann K; Jonasson J; Pietsch T; Jonas U; Schmoll H J
Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours.
Journal of cancer research and clinical oncology 1996;122(5):301-6.
1995: Kuczyk M A; Bokemeyer C; Serth J; Hervatin C; Oelke M; Höfner K; Tan H K; Jonas U
p53 overexpression as a prognostic factor for advanced stage bladder cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(13-14):2243-7.
1995: Berger C C; Bokemeyer C; Schneider M; Kuczyk M A; Schmoll H J
Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(13-14):2229-38.
1995: Kuczyk M A; Serth J; Bokemeyer C; Jonassen J; Arndt H; Paeslack U; Werner M; Tan H K; Jonas U
Detection of p53 gene alteration in renal-cell cancer by micropreparation techniques of tumor specimens.
International journal of cancer. Journal international du cancer 1995;64(6):399-406.
1995: Kuczyk M A; Bokemeyer C; Fichna B; Truss M; Schmoll H J; Jonas U
[Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ cell tumor. Case report and clinical problems]
Der Urologe. Ausg. A 1995;34(6):480-4.
1995: Kuczyk M A; Serth J; Bokemeyer C; Hervatin C; Oelke M; Oelert F; Höfner K; Jonas U
[Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder]
Der Urologe. Ausg. A 1995;34(2):146-52.
1995: Serth J; Kuczyk M A; Bokemeyer C; Hervatin C; Nafe R; Tan H K; Jonas U
p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder.
British journal of cancer 1995;71(1):201-5.
1995: Bokemeyer C; Schmoll H J
Treatment of testicular cancer and the development of secondary malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):283-92.
1995: Bokemeyer C; Kynast B; Harstrick A; Laage E; Schmoll E; von Wussow P; Schmoll H J
No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinoma.
Cancer chemotherapy and pharmacology 1995;35(4):334-8.
1995: Kuczyk M A; Bokemeyer C; Djamilian M; Thon W F; Höfner K; Jonas U
Bilateral metachronous testicular germ cell tumors occurring in two non-twin brothers. Case report and review of the literature.
Urologia internationalis 1995;55(1):41-3.
1994: Bokemeyer C; Harstrick A; Rüther U; Metzner B; Illiger H J; Clemm C; Siegert W; Link H; Ostermann H; Schmoll H J
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study Group.
Seminars in oncology 1994;21(6 Suppl 16):57-63.
1994: Kuczyk M A; Serth J; Bokemeyer C; Allhoff E P; Jonassen J; Kuczyk S; Jonas U
Overexpression of the p53 oncoprotein in carcinoma in situ of the testis.
Pathology, research and practice 1994;190(11):993-8.
1994: Bokemeyer C; Schmoll H J; Poliwoda H
[Secondary leukemias after etoposide chemotherapy]
Deutsche medizinische Wochenschrift (1946) 1994;119(19):707-13.
1994: Bokemeyer C; Schmoll H J; Ludwig E; Harstrick A; Dunn T; Casper J
The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna.
British journal of cancer 1994;69(5):863-7.
1994: Kuczyk M A; Bokemeyer C; Thon W F; Serth J; Allhoff E P; Jonas U
[Metastatic adult teratoma of the testis. Possibilities of chemotherapy and surgical treatment]
Der Urologe. Ausg. A 1994;33(2):149-53.
1994: Bokemeyer C; Schmoll H J; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Annals of hematology 1994;68(3):105-10.
1994: Bokemeyer C; Schmoll H J; Natt F; Knoche M; Beyer J; Souchon R
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
Journal of cancer research and clinical oncology 1994;120(12):754-7.
1993: Schöber C; Papageorgiou E; Harstrick A; Bokemeyer C; Mügge A; Stahl M; Wilke H; Poliwoda H; Hiddemann W; Köhne-Wömpner C H
Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer.
Cancer 1993;72(7):2242-7.
1993: Bokemeyer C; Schmoll H J
Secondary neoplasms following treatment of malignant germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(9):1703-9.
1993: Bokemeyer C; Schmoll H J; Metzner B; Beyer J; Illiger H J; Kneba M; Ostermann H; Kynast B; Räth U; Poliwoda H
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer.
Annals of hematology 1993;67(2):75-9.
1993: Schmoll H J; Harstrick A; Bokemeyer C; Dieckmann K P; Clemm C; Berdel W E; Souchon R; Schöber C; Wilke H; Poliwoda H
Single-agent carboplatinum for advanced seminoma. A phase II study.
Cancer 1993;72(1):237-43.
1993: Harstrick A; Bokemeyer C; Schmoll H J; Köhne-Wömpner C H; Knipp H; Schöffski P; Anagnou J; Wipperman B; Neumann S; Poliwoda H
A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults.
Cancer chemotherapy and pharmacology 1993;31 Suppl 2():S217-21.
1993: Grundner-Culemann E; Bokemeyer C; Neubauer V; Shalitin C; Schmoll H J; Poliwoda H; Benter T
Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors.
Journal of cancer research and clinical oncology 1993;119(11):685-8.
1993: Bokemeyer C; Schmoll H J
Treatment strategies in metastatic testicular cancer.
European urology 1993;23 Suppl 2():50-2.
1993: Bokemeyer C; Schmoll H J; Schöffski P; Harstrick A; Bading M; Poliwoda H
Bilateral testicular tumours: prevalence and clinical implications.
European journal of cancer (Oxford, England : 1990) 1993;29A(6):874-6.
1993: Bokemeyer C; Schmoll H J; Harstrick A; Illiger H J; Metzner B; Räth U; Hohnloser J; Clemm C; Berdel W; Siegert W
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours.
European journal of cancer (Oxford, England : 1990) 1993;29A(16):2225-31.
1993: Bokemeyer C; Schmoll H J
Treatment of advanced germ cell tumours by dose intensified chemotherapy with haematopoietic growth factors or peripheral blood stem cells (PBSC).
European urology 1993;23(1):223-9; discussion 230.
1992: Schmoll H J; Bokemeyer C; Harstrick A; Illiger H J; Metzner B; Ruther U; Osternamm A; Preiss J; Wilke H; Hohnloser J
Dose escalation of cisplatin (P), etoposide (E), and ifosfamide (I) with GM-CSF for advanced germ cell tumors.
Pathologie-biologie 1992;39(9):961.
1992: Bokemeyer C; Harstrick A; Schöffski P; Schmoll H J; Poliwoda H
[Germ-cell tumors of the testis. The epidemiological and etiological aspects]
Deutsche medizinische Wochenschrift (1946) 1992;117(40):1532-7.
1992: Bokemeyer C; Harstrick A; Schmoll H J; Köhne-Wömpner C H; Schöffski P; Poliwoda H
Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(6):487-8.
1992: Schmoll H J; Köhne-Wömpner C H; Hiddemann W; Knipp H; Wilke H; Bodenstein H; Schöffski P; Bokemeyer C; Lohrmann H P; Preiss J
Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced colorectal cancer: preliminary results of a phase I/II trial.
Seminars in oncology 1992;19(2 Suppl 3):191-6.
1992: Schöber C; Bokemeyer C; Stahl M; Wilke H J; Schmoll H J; Poliwoda H
The role of schedule dependency of 5-fluorouracil/leucovorin combinations in advanced colorectal cancer.
Seminars in oncology 1992;19(2 Suppl 3):131-5.
1992: Harstrick A; Bokemeyer C; Preusser P; Köhne-Wömpner C H; Meyer H J; Stahl M; Knipp H; Schmoll H J; Wilke H
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus.
Cancer chemotherapy and pharmacology 1992;29(4):321-2.
1992: Schöber C; Schmoll E; Schmoll H J; Poliwoda H; Schuppert F; Stahl M; Bokemeyer C; Wilke H; Weiss J
Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours.
European journal of cancer (Oxford, England : 1990) 1992;28A(10):1664-6.
1991: Harstrick A; Schmoll H J; Wilke H; Köhne-Wömpner C H; Stahl M; Schöber C; Casper J; Bruderek L; Schmoll E; Bokemeyer C
Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1549-55.
1991: Harstrick A; Schmoll H J; Bokemeyer C; Metzner B; Illiger H J; Berdel W; Ostermann H; Manegold C; Räth U; Siegert W
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma.
Journal of cancer research and clinical oncology 1991;117 Suppl 4():S198-202.
1990: Harstrick A; Schmoll H J; Wilke H; Schöber C; Stahl M; Wömpner C K; Bokemeyer C; Dölken G; Burk K; Poliwoda H
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(5):375-6.
1988: Verbeek W; Bokemeyer C; Falk H; Schmoll H J
Growth requirements, growth factor responsiveness, and growth factor secretion of three human embryonal carcinoma cell lines.
Journal of cancer research and clinical oncology 1988;114(6):553-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Carsten Bokemeyer

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Carsten Bokemeyer (preview)

All Publications